Invention Grant
- Patent Title: Compositions and methods for modifying a predetermined target nucleic acid sequence
-
Application No.: US15582384Application Date: 2017-04-28
-
Publication No.: US10220052B2Publication Date: 2019-03-05
- Inventor: Yoel Moshe Shiboleth , Dan Michael Weinthal
- Applicant: TARGETGENE BIOTECHNOLOGIES LTD.
- Applicant Address: IL D.N. Hefer
- Assignee: TARGETGENE BIOTECHNOLOGIES LTD
- Current Assignee: TARGETGENE BIOTECHNOLOGIES LTD
- Current Assignee Address: IL D.N. Hefer
- Agency: Arnold & Porter Kaye Scholer LLP
- Main IPC: C12N15/82
- IPC: C12N15/82 ; C12N15/00 ; C12N15/10 ; C12N9/22 ; A61K31/7105 ; C12N15/62 ; A61K38/00 ; C12N15/90 ; C07K19/00 ; A61K31/711 ; A61K31/7115 ; A61K31/712 ; A61K31/7125 ; A61K31/713 ; A61K48/00

Abstract:
Provided herein are compositions and methods for modifying a predetermined nucleic acid sequence. A programmable nucleoprotein molecular complex containing a polypeptide moiety and a specificity conferring nucleic acid (SCNA) which assembles in-vivo, in a target cell, and is capable of interacting with the predetermined target nucleic acid sequence is provided. The programmable nucleoprotein molecular complex is capable of specifically modifying and/or editing a target site within the target nucleic acid sequence and/or modifying the function of the target nucleic acid sequence.
Public/Granted literature
- US20170233752A1 Compositions and Methods for Modifying a Predetermined Target Nucleic Acid Sequence Public/Granted day:2017-08-17
Information query
IPC分类: